Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Conditions

Polycystic Ovary Syndrome 3Fatty Liver 2Diabetes Mellitus 2Thyroid Neoplasms 1Obesity 1Neoplasms 1Menstruation Disturbances 1Lymphoma, T-Cell, Cutaneous 1Hypertriglyceridemia 1Hyperthyroidism 1Graves Disease 1Glucose Metabolism Disorders 1Glucose Intolerance 1Fibrous Dysplasia, Polyostotic 1Fibrous Dysplasia of Bone 1

Interventions

Metformin 7Surveys and Questionnaires 3Nutrition Assessment 3Exercise 3Tirzepatide 2Therapeutics 2Tablets 2Standard of Care 2Specimen Handling 2Resistance Training 2Methods 2Interviews as Topic 2Glucose Tolerance Test 2Educational Status 2Biopsy 2tocilizumab 1tislelizumab 1pembrolizumab 1epalrestat 1donafenib 1amlodipine, atorvastatin drug combination 1Verapamil 1Urine Specimen Collection 1Testosterone 1Secretin 1Second Harmonic Generation Microscopy 1Risk Assessment 1Remote Consultation 1Preventive Health Services 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus × Glucose Tolerance Test × Clear all
NCT03415139 2022-03-28

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Vanderbilt-Ingram Cancer Center

Unknown
120 enrolled

Diabetes Mellitus, Neoplasms

NCT03520153 2019-09-04

Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome

Yale University

Withdrawn

Diabetes Mellitus, Fibrous Dysplasia of Bone, Fibrous Dysplasia, Polyostotic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡